Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid Leukemia Chemo-Resistance in Hypoxic Microenvironment

por Huang, Jixian, Lu, Ziyuan, Xiao, Yajuan, He, Bolin, Pan, Chengyun, Zhou, Xuan, Xu, Na, Liu, Xiaoli
Publicado 2018

Multi-Scale Influencing Factors and Prediction Analysis: Dongxing Port–City Relationship

por Wu, Bin, Gu, Guanhai, Zhang, Wenzhu, Zhang, Liguo, Lu, Rucheng, Pang, Caiping, Huang, Jixian, Li, Hongxin
Publicado 2022

Therapeutic immune monitoring of CD4(+)CD25(+) T cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

por Lu, Ziyuan, Xu, Na, Zhou, Xuan, Gao, Guanlun, Li, Lin, Huang, Jixian, Li, Yuling, Lu, Qisi, He, Bolin, Pan, Chengyun, Liu, Xiaoli
Publicado 2017

Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase Inhibitor

por Wu, Waner, Xu, Na, Zhou, Xuan, Liu, Liang, Tan, Yaxian, Luo, Jie, Huang, Jixian, Qin, Jiayue, Wang, Juan, Li, Zhimin, Yin, Changxin, Zhou, Lingling, Liu, Xiaoli
Publicado 2020

De‐escalation or discontinuation of tyrosine kinase inhibitor in patients with chronic myeloid leukemia: A multicentral, open‐label, prospective trial in China

por Luo, Jie, Du, Xin, Lou, Jin, Wu, Jianwei, Ma, Liping, Huang, Jixian, Wang, Liangtuo, Tu, Chuanqing, Liu, Zelin, Chen, Liya, Tan, Yaxian, Luo, Dongmei, Liang, Hanyin, Yin, Changxin, Cao, Rui, Zhou, Xuan, Liu, Qifa, Liu, Xiaoli, Xu, Na
Publicado 2022